control group:apatinib

2 trials

Sponsors

Sanxia Hospital of Chongqing University, Changhai Hospital of Second Military Medical University

Conditions

Hepatocellular carcinomaovarian cancer

Early Phase 1

A clinical study on the treatment of inoperable middle and advanced stage of HCC with SIB-IMRT low-dose fractionation radiotherapy combined with Apatinib

Active, not recruitingChiCTR2000029551

Sanxia Hospital of Chongqing UniversityHepatocellular carcinoma

Start: 2020-07-01Updated: 2020-05-18

Unknown Phase

Apatinib plus Docetaxel for Treating Taxol Resistant Patients with Ovarian Cancer

RecruitingChiCTR-IOR-17011622

Changhai Hospital of Second Military Medical Universityovarian cancer

Start: 2017-06-12Updated: 2017-06-12